Immunis, Inc. funding
Immunis, Inc., a biotechnology company based in Irvine, CA, filed a Form D with the SEC on June 15, 2026 and reported $12M raised.
Amount raised$12M
Offering size$12M
Filed with the SECJune 15, 2026
First saleMay 28, 2026
IndustryBiotechnology
SecuritiesOptions or warrants, Other
LocationIrvine, CA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far12
Minimum investment$50K
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Jun 15
Other health care rounds in California
Alpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyCaspian Therapeutics, Inc.$50M · Sep 23BiotechnologyEstuary Biotherapeutics, Inc.$40.7M · Oct 16BiotechnologyPFARADIGM Health, Inc.$31.1M · Sep 28Other Health CareTrellis Bioscience, Inc.$22.9M · Oct 21BiotechnologyAltay Therapeutics, Inc.$15.7M · Oct 2BiotechnologyAdela, Inc.$12M · Oct 19Biotechnology